Original Investigation

Impact of Removing the Universal Hepatitis B Birth-Dose Vaccination in the US

JAMA Pediatrics 10.1001/jamapediatrics.2026.1226

April 27, 2026 at 11:00 AM EDT

Read the full article

What is the impact of replacing the universal hepatitis B virus (HBV) birth-dose vaccine recommendation with a targeted recommendation limited to infants of screened-positive or unscreened mothers?In this modeling study, the targeted recommendation resulted in more neonatal infections than universal vaccination under current maternal screening and birth-dose vaccination coverage. Preventing these additional infections would require screening approximately 100 000 more women.Targeted vaccination would likely increase neonatal infections even at current screening and vaccination levels; because vaccination coverage has historically declined when universal recommendations were withdrawn, the impact of such a change is likely to be greater.

Corresponding Author: Margaret L. Lind, PhD, School of Public Health, Boston University, 715 Albany St, Boston, MA 02118 (mllind@bu.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.1226?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=042726

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks